Comments: TN SB2099 | 2017-2018 | 110th General Assembly

Bill Title: As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63.

Spectrum: Moderate Partisan Bill (Republican 5-1)

Status: (Passed) 2018-04-17 - Comp. became Pub. Ch. 674 [SB2099 Detail]

Text: Latest bill text (Chaptered) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2017 Tennessee SB2099 at this time.

Social Comments on TN SB2099

feedback